The publication of University of Health Sciences Istanbul Sisli Hamidiye Etfal Application and Research Center.


Online article submission system has been turned over to eJManager. We kindly request you to submit your current article or new articles via eJManager system

          VOLUME 36 / ISSUE 2


The Journal is Indexed in


11 - Coming out of the hypercalcemic coma dramatically by applying iv pamidronate and sc calcitonin concomitant treatment which is due to very seldom etiology

Mehtap Dalkılıç Çalış, Gül Çağrı Erol, Fatih Borlu, Ebru Em, Hülya Tanes Açıkel

The plasma calcium is maintained at a remarkably constant concentration by a complex homeostatic mechanism which is only partially understood. A multitude of cell and organ functions are dependent on the maintenance of the extracellular fluid calcium concentration within a very narrow range. Hypercalcemia is rarely a presenting sign of malignency, except in patients with parathyroid carcinoma, human T-cell lympotropic virus type-1 lymphoma, or multiple myeloma. In this article, a rarely occured coma of hypercalcemia due to very seldom etiology is presented and then coming out of the coma dramatically by applying IV Pamidronate and SC Calcitonin concomitant treatment and interesting clinic progress is explained.

Result: Clinicians are frequently confronted with hypercalcemia as an isolated laboratory abnormality. In practice 90 percent of cases are due either to primary hyperparathyroidism or to malignancy. Thus, the first two conditions that the clinician considers when faced with differential diagnosis of hypercalcemia is whether the underlying disorder responsible is malignancy or primary hyperparathyroidism.

Keywords: The coma of hypercalcemia, malignency, stomach carcinoma, pamidronate, calcitonin.

To read full article click


Home Page       Editorial       Editorial Board       Advisory Board       Information for Authors       Contact       Archive

Copyright ® 2011 Sisli Etfal Hastanesi Tıp Bülteni